Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
GDRX logo GDRX
Upturn stock ratingUpturn stock rating
GDRX logo

Goodrx Holdings Inc (GDRX)

Upturn stock ratingUpturn stock rating
$3.54
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/14/2025: GDRX (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

16 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $5.37

1 Year Target Price $5.37

Analysts Price Target For last 52 week
$5.37 Target price
52w Low $3.31
Current$3.54
52w High $8.8

Analysis of Past Performance

Type Stock
Historic Profit -65.98%
Avg. Invested days 21
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/14/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.23B USD
Price to earnings Ratio 39.33
1Y Target Price 5.37
Price to earnings Ratio 39.33
1Y Target Price 5.37
Volume (30-day avg) 16
Beta 1.24
52 Weeks Range 3.31 - 8.80
Updated Date 08/15/2025
52 Weeks Range 3.31 - 8.80
Updated Date 08/15/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.09

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-08-06
When -
Estimate 0.1
Actual 0.09

Profitability

Profit Margin 4.33%
Operating Margin (TTM) 13.2%

Management Effectiveness

Return on Assets (TTM) 4.88%
Return on Equity (TTM) 5.27%

Valuation

Trailing PE 39.33
Forward PE 9.57
Enterprise Value 1496192977
Price to Sales(TTM) 1.54
Enterprise Value 1496192977
Price to Sales(TTM) 1.54
Enterprise Value to Revenue 1.87
Enterprise Value to EBITDA 8.4
Shares Outstanding 98580704
Shares Floating 82766063
Shares Outstanding 98580704
Shares Floating 82766063
Percent Insiders 12.74
Percent Institutions 66.39

ai summary icon Upturn AI SWOT

Goodrx Holdings Inc

stock logo

Company Overview

overview logo History and Background

GoodRx was founded in 2011 by Doug Hirsch, Trevor Bezdek, and Scott Marlette. Initially focused on aggregating and comparing prescription drug prices, it has grown to offer telehealth services and other healthcare offerings. The company went public in September 2020.

business area logo Core Business Areas

  • Prescription Transactions: Provides price comparisons and discount codes for prescription medications, generating revenue from pharmacy benefit managers (PBMs) and pharmacies when users fill prescriptions using GoodRx codes.
  • Subscription Offerings: Offers subscription programs like GoodRx Gold and Kroger Rx Savings Club, providing deeper discounts and other benefits for a monthly fee.
  • Pharma Manufacturer Solutions: Provides services to pharmaceutical manufacturers, including advertising, market research, and adherence programs.
  • Telehealth: Offers telehealth services through its acquisition of HeyDoctor in 2019, connecting patients with healthcare providers for virtual consultations and prescriptions.

leadership logo Leadership and Structure

Scott Wagner is the Interim CEO. The company has a traditional corporate structure with a board of directors and various executive leadership positions overseeing different functional areas.

Top Products and Market Share

overview logo Key Offerings

  • Prescription Price Comparisons & Discounts: GoodRx's core product, allowing users to compare prices and access discounts on prescription drugs. Estimated to facilitate billions in prescription transactions annually. Competitors: SingleCare, Optum Perks, RxSaver.
  • GoodRx Gold: Subscription service offering deeper discounts on medications. Number of subscribers undisclosed but a significant revenue driver. Competitors: Kroger Rx Savings Club, various PBM discount programs.
  • Telehealth (GoodRx Care): Virtual healthcare services providing online consultations and prescriptions. Growing rapidly, with increasing user adoption. Competitors: Teladoc Health (TDOC), Amwell (AMWL).

Market Dynamics

industry overview logo Industry Overview

The healthcare industry is undergoing rapid digitalization and consumerization. Increasing drug prices and lack of price transparency are driving demand for solutions like GoodRx. Telehealth is experiencing significant growth due to convenience and accessibility.

Positioning

GoodRx is a leading player in the prescription drug price transparency and discount market. Its competitive advantages include brand recognition, a large user base, and strong relationships with pharmacies and PBMs.

Total Addressable Market (TAM)

The TAM for prescription drug discounts and telehealth is estimated to be in the tens of billions of dollars. GoodRx is well-positioned to capture a significant share of this market through its price transparency and accessibility.

Upturn SWOT Analysis

Strengths

  • Strong Brand Recognition
  • Large User Base
  • Extensive Pharmacy Network
  • Data-Driven Insights
  • Proven Business Model

Weaknesses

  • Reliance on PBM Relationships
  • Potential for Regulatory Changes
  • Competition from Established Players
  • Dependence on Google Search Ranking
  • Telehealth is very competitive

Opportunities

  • Expansion into New Healthcare Services
  • Partnerships with Healthcare Providers
  • International Expansion
  • Growth in Telehealth Adoption
  • Increased Focus on Medication Adherence

Threats

  • Increased Competition
  • Changes in PBM Pricing Models
  • Data Privacy Concerns
  • Economic Downturn Impacting Healthcare Spending
  • Regulatory Scrutiny

Competitors and Market Share

competitor logo Key Competitors

  • TDOC
  • AMWL
  • CVS
  • WBA

Competitive Landscape

GoodRx faces competition from established players in the pharmacy and healthcare industries. Its competitive advantages include its strong brand recognition, large user base, and data-driven insights. Competitors are catching up in terms of user experience and breadth of service offerings.

Major Acquisitions

HeyDoctor

  • Year: 2019
  • Acquisition Price (USD millions):
  • Strategic Rationale: Expanded GoodRx's telehealth capabilities.

Growth Trajectory and Initiatives

Historical Growth: GoodRx experienced rapid growth in its early years, driven by increasing demand for prescription drug discounts. Growth has slowed somewhat in recent years.

Future Projections: Analysts project continued revenue growth for GoodRx, driven by expansion into new healthcare services and increased adoption of telehealth. Earnings growth is expected to be impacted by investments in growth initiatives.

Recent Initiatives: Focus on expanding telehealth offerings, developing partnerships with healthcare providers, and improving medication adherence programs.

Summary

GoodRx is a prominent player in the prescription drug price comparison market with a strong brand and user base. While it faces increasing competition and regulatory uncertainties, its growth trajectory is supported by expanding telehealth services and strategic partnerships. The company has a solid financial position but must continue to innovate and adapt to maintain its competitive edge. The high net loss is a point of concern that the company must work on.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • GoodRx Investor Relations
  • SEC Filings (10-K, 10-Q)
  • Market Research Reports
  • Analyst Estimates

Disclaimers:

This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance are subject to change. Actual results may vary.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Goodrx Holdings Inc

Exchange NASDAQ
Headquaters Santa Monica, CA, United States
IPO Launch date 2020-09-23
President, CEO & Director Ms. Wendy Barnes
Sector Healthcare
Industry Health Information Services
Full time employees 738
Full time employees 738

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solution for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.